Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3753796
Max Phase: Preclinical
Molecular Formula: C17H23N2O6PS
Molecular Weight: 414.42
Molecule Type: Small molecule
Associated Items:
ID: ALA3753796
Max Phase: Preclinical
Molecular Formula: C17H23N2O6PS
Molecular Weight: 414.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(S(=O)(=O)N(Cc2cccnc2)C(C(C)C)P(=O)(O)O)cc1
Standard InChI: InChI=1S/C17H23N2O6PS/c1-13(2)17(26(20,21)22)19(12-14-5-4-10-18-11-14)27(23,24)16-8-6-15(25-3)7-9-16/h4-11,13,17H,12H2,1-3H3,(H2,20,21,22)
Standard InChI Key: SQRCOVLYHLVMCB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 414.42 | Molecular Weight (Monoisotopic): 414.1014 | AlogP: 2.44 | #Rotatable Bonds: 8 |
Polar Surface Area: 117.03 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.47 | CX Basic pKa: 4.81 | CX LogP: -0.48 | CX LogD: -0.90 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.64 | Np Likeness Score: -1.01 |
1. Beutel B, Daniliuc CG, Riemann B, Schäfers M, Haufe G.. (2016) Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography., 24 (4): [PMID:26810711] [10.1016/j.bmc.2016.01.017] |
Source(1):